John Ducas

Abciximab Facilitates the Rate and Extent of Thrombolysis

Elliott M. Antman, Robert P. Giugliano, C. Michael Gibson et al. · Circulation · 1999 · 687 citations · Full text

Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction

Warren J. Cantor, David Fitchett, Bjug Borgundvaag et al. · New England Journal of Medicine · 2009 · 578 citations

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

A. Michael Lincoff, Robert M. Califf, David J. Moliterno et al. · New England Journal of Medicine · 1999 · 379 citations

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

Duncan J. Stewart, Jennifer M. Arnold, Jean‐Claude Grégoire et al. · Gene Therapy · 2006 · 282 citations

Gene Therapies, Vascular Disease, Translational Medicine +11

Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease

G.B. John Mancini, Gilbert Gosselin, Benjamin J.W. Chow et al. · Canadian Journal of Cardiology · 2014 · 164 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Health Policy +10